Detalhe da pesquisa
1.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med;
21(3): e1004360, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38502656
2.
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
N Engl J Med;
384(12): 1089-1100, 2021 03 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33761206
3.
Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.
Clin Infect Dis;
76(5): 881-889, 2023 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36250382
4.
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
J Infect Dis;
226(2): 246-257, 2022 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35758878
5.
Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa.
BMC Pregnancy Childbirth;
22(1): 596, 2022 Jul 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35883114
6.
Acceptability of Early Antiretroviral Therapy Among South African Women.
AIDS Behav;
22(3): 1018-1024, 2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28224322
7.
Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting.
AIDS Behav;
19(7): 1305-16, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25662962
8.
Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa.
Int J STD AIDS;
35(1): 58-66, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37751624
9.
Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.
Vaccine;
2024 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38772835
10.
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa.
J Infect Dis;
206(1): 6-14, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22517910
11.
Incidence, recurrence, and prevalence of bacterial vaginosis from acute to chronic HIV infection in a prospective cohort of women in South Africa.
Ann Epidemiol;
82: 33-39, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37037344
12.
High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
PLoS One;
18(11): e0294698, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38032961
13.
Burden of sexually transmitted infections from acute HIV infection among women in South Africa: Evidence from a prospective cohort study.
Ann Epidemiol;
74: 132-139, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35977656
14.
Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African Clinics.
J Acquir Immune Defic Syndr;
91(2): 189-196, 2022 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36094486
15.
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.
BMJ Open;
11(10): e050116, 2021 10 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34610939
16.
Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries.
PLoS One;
13(4): e0196209, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29689080
17.
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.
Antivir Ther;
22(4): 287-293, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27835613
18.
Metabolic Syndrome After HIV Acquisition in South African Women.
J Acquir Immune Defic Syndr;
73(4): 438-445, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27391387
19.
Low CD4 count and educational status predict abnormal cervical smears amongst HIV-positive women initiating antiretroviral therapy in South Africa.
South Afr J HIV Med;
21(1): 1045, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32284889
20.
HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.
J Acquir Immune Defic Syndr;
68(1): 55-61, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25247433